BioCryst Pharmaceuticals Inc
$8.65
$0.21 (+2.55%)
$8.43Day Range$8.72
Key Statistics
Market Cap
$2.15B
Shares Outstanding
255.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 3, 1994
Round Lot
100
Locale
US
Trading Data
Day Open
$8.54
Day High
$8.72
Day Low
$8.43
Volume
2.38M
VWAP
$8.63
Prev Close
$8.43
Transactions
--
Acc. Volume
--
About BioCryst Pharmaceuticals Inc
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836435 employees4505 EMPEROR BOULEVARD, DURHAM, NC, 27703919-859-1302IPO Mar 3, 1994US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000882796
- Composite FIGI
- BBG000BLYWX6
- Share Class FIGI
- BBG001S7K151
- Ticker Root
- BCRX
- SIC Code
- 2836
About BioCryst Pharmaceuticals Inc (BCRX) Stock
BioCryst Pharmaceuticals Inc (BCRX) closed the 2026-09-17 session at $8.64, up 2.55% versus the previous close (+0.21). The stock opened at $8.54 and traded between $8.43 and $8.72 during that session. Session trading volume was 2.4M shares. The volume-weighted average price (VWAP) is $8.63.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
BioCryst Pharmaceuticals Inc has a market capitalization of $2.15 billion. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. BCRX is listed on the XNAS exchange. The company employs approximately 435 people. BioCryst Pharmaceuticals Inc is headquartered in DURHAM, NC. The recorded listing date is 1994-03-03.
On this page you can find market BCRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.